Parkinson’s disease studies face unique challenges. For one, patients often suffer from disabling neuropsychiatric symptoms that can make study participation difficult. The effective and efficient collection of remote, patient-reported data and digital outcomes is also required in today’s studies. Finally, the reliability of clinician-reported outcomes, and the expertise to interpret the data, is critical to detect signals. That’s where Signant Health’s solutions can help.
